[Technology and Achievements] Technology for Controlled Release Formulations (such as Sustained Release Matrix Tablets)
Achieve reduced Cmax and longer exposure! Introducing the mechanism of sustained release from Gelmatrix tablets.
We would like to introduce our technology for "Release Control Formulations (Extended Release Matrix Tablets, Gastroretentive Formulations)." Even with reduced dosing intervals, we achieve lower Cmax and longer exposure. We have successfully developed formulations using this technology and are applying it to investigational drugs targeting compounds in the development stage. We respond to all requests related to CMC from the early stages of development to application. Please feel free to contact us when needed. 【Features】 ■ Achieves lower Cmax and longer exposure even with reduced dosing intervals ■ Successful development of formulations using this technology ■ Application to investigational drugs targeting compounds in the development stage *For more details, please refer to the PDF materials or feel free to contact us.
Inquire About This Product
basic information
For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
Our company is a pharmaceutical CMC research and development contract company that spun out from the CMC research division of Takeda Pharmaceutical Company Limited in July 2017. We support excellent pharmaceutical development as experts in CMC research. Our research team consists of experts with extensive experience and achievements in process chemistry, formulation research and development, and analytical testing development related to CMC research. We provide high-level services and solutions tailored to our customers' needs across each process from the early stages of pharmaceutical development to application, while flexibly collaborating. We have established a collaborative system with partner companies, enabling us to offer a one-stop service. Please utilize us as a platform for your pharmaceutical development.
![[Technology and Achievements] Technology of Release Control Formulations (Sustained Release Granules)](https://image.mono.ipros.com/public/product/image/79c/2000706990/IPROS86781430938375110980.png?w=280&h=280)
![[Technology and Achievements Introduction] Absorption Improvement Technology (Solid Dispersion Formulation)](https://image.mono.ipros.com/public/product/image/a05/2000706998/IPROS72145712481370582875.png?w=280&h=280)
![[Research Achievements] Paper published in AAPS PharmSciTech.](https://image.mono.ipros.com/public/product/image/f5d/2000716677/IPROS02439048154143915532.png?w=280&h=280)
